Healthcare | October 10, 2024
WHO declares India has eliminated Trachoma as a public health problem in 2024
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
The acquisition will strengthen the overall company’s position as leading global CRO services partner
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
USFDA completes PAI of Lupin’s biotech facility in Pune
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Subscribe To Our Newsletter & Stay Updated
